<乌鸦传媒>FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer Novel immunotherapy induced complete responses in 62% of patients with BCG-unresponsive NMIBC Apr 23, 2024
<乌鸦传媒>Neurotechnology Development Must Be Slow and Steady The burgeoning field holds both promise and risks Apr 22, 2024
<乌鸦传媒>Make the Diagnosis: Why Does This Young Woman Have Discoloration on Her Back? A 24-year-old woman visited her doctor about discoloration that developed on her back over the past 3 months. Can you diagnose the patient? Apr 22, 2024
<乌鸦传媒>Paxlovid and COVID; Breast Cancer and Lymph Node Removal Also in TTHealthWatch: pragmatic model for chronic kidney disease Apr 20, 2024 podcast
<乌鸦传媒>Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT No difference in freedom from distant metastasis or overall survival at 10 years Apr 19, 2024
<乌鸦传媒>Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests News, features, and commentary about cancer-related issues Apr 19, 2024
<乌鸦传媒>Alectinib Lands FDA Approval for Adjuvant Therapy in NSCLC The ALK inhibitor reduced the risk of recurrence or death by 76% versus chemotherapy Apr 19, 2024
<乌鸦传媒>Urine Test Accurately Detected High-Grade Prostate Cancer Researchers say use of the test could substantially reduce unnecessary biopsies Apr 18, 2024
<乌鸦传媒>California Sets Long-Awaited Drinking Water Limit for 'Erin Brockovich' Contaminant The rule is the first in the nation to specifically target the heavy metal Apr 18, 2024
<乌鸦传媒>FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy Pegulicianine used with an approved imaging system achieved overall diagnostic accuracy of 84% Apr 18, 2024
<乌鸦传媒>FDA Slaps Embolization Device With Class I Recall After Deaths Increased bowel ischemia risk when Obsidio Embolic is used for lower GI bleeds Apr 17, 2024
<乌鸦传媒>Deeper Sedation During Colonoscopy Linked to Improved Detection of Serrated Polyps Propofol boosts serrated polyp detection by 50%, little difference for all neoplasia, adenomas Apr 17, 2024
<乌鸦传媒>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
<乌鸦传媒>Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance? Experts suggest his apparent situation is rare Apr 17, 2024
<乌鸦传媒>Roundup Maker Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer Legal experts say legislation could provide immunity from lawsuits Apr 16, 2024
<乌鸦传媒>Automated, Personalized Outreach Boosts CRC Screening in Diverse Patient Population Absolute improvement of 30-40% in screening participation after 1 year Apr 16, 2024
<乌鸦传媒>Many With Breast Cancer 'Systematically Left Behind,' Report Says Lancet Commission issues recommendations to address inequities in global breast cancer care Apr 15, 2024
<乌鸦传媒>Don't Rule Out Breast Cancer Surgery for 90-Year-Olds Retrospective study suggests survival benefit over conservative management Apr 15, 2024
<乌鸦传媒>What Kate Middleton Reminds Us About the Role of Privacy in Healing Everyone deserves the "sanctity of space" during a course of illness Apr 15, 2024
<乌鸦传媒>Cryoablation for Early-Stage Breast Cancer a Safe Option in Older Women Breast cancer survival rate was 97% at 5 years Apr 15, 2024
<乌鸦传媒>Journey Into Virtual Reality Eases Cancer Pain VR distraction therapy could be a useful non-pharmacologic alternative, study suggests Apr 12, 2024
<乌鸦传媒>Possible New Standard for Treated Advanced CRC With KRAS Mutations Adagrasib plus cetuximab leads to responses in one-third of patients, median OS of 15.9 months Apr 12, 2024
<乌鸦传媒>'I'm Dying, You're Not': Terminally Ill Ask More States for Physician-Assisted Death Debates on medical aid in dying bills are playing out in Kentucky, Delaware, Maryland, and Iowa Apr 12, 2024
<乌鸦传媒>Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis Former NIH director said he went public to "share lifesaving information" Apr 12, 2024
<乌鸦传媒>Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol? News, features, and commentary about cancer-related issues Apr 12, 2024
<乌鸦传媒>1,000 Paper Cranes Can Bring Our Patients One Step Closer to Healing We must remind our patients to hold on to hope Apr 11, 2024
<乌鸦传媒>O.J. Simpson Dies After Cancer Battle Football star who was acquitted of murders but later found liable in civil trial dead at 76 Apr 11, 2024
<乌鸦传媒>Neoadjuvant Chemo-IO Promising in Borderline Resectable Pancreatic Cancer Combination associated with favorable R0 resection and survival rates Apr 10, 2024
<乌鸦传媒>Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
<乌鸦传媒>Bispecific Checkpoint Inhibitor Improves Survival in Advanced Gastric/GEJ Cancer Almost 50% improvement in median survival, but against a suboptimal control regimen Apr 10, 2024
<乌鸦传媒>Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer No event-free survival benefit with atezolizumab versus placebo in phase III trial Apr 10, 2024
<乌鸦传媒>Biden Admin Imposes National Limits on 'Forever Chemicals' in Drinking Water Most important action the EPA has ever taken on PFAS, says agency administrator Apr 10, 2024
<乌鸦传媒>Cancer Warnings on Booze; Rats, Roaches in Hospitals; Barefoot Pharma Workers Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 10, 2024
<乌鸦传媒>Why Aren't Some Women Getting Screening Mammograms? Social Factors May Be to Blame Cost concerns, lack of transportation, and social isolation may all contribute, CDC study finds Apr 09, 2024
<乌鸦传媒>Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors Strength of association increased in more recent birth cohorts Apr 09, 2024
<乌鸦传媒>Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
<乌鸦传媒>FDA Approves Earlier Use of CAR-T Products for Myeloma Carvykti and Abecma move to second- and third-line, respectively Apr 08, 2024
<乌鸦传媒>High Response Rate in R/R Multiple Myeloma With Bispecific Antibody ORR of 71% that deepened over time and favorable safety profile with linvoseltamab Apr 08, 2024
<乌鸦传媒>Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
<乌鸦传媒>Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials Only 43% showed clinical benefit within 5 years Apr 08, 2024
